Bizarre CRISPR enzyme kills cancer cells by shredding their DNA

TL;DR - Early studies suggest an unusual CRISPR enzyme can be directed at tumour-causing mutations to kill cancer cells by shredding their DNA. The limited summary does not specify efficacy, safety, or experimental models.

• The enzyme appears targetable to cancer-associated genetic mutations.
• Its proposed mechanism is broad DNA destruction within targeted cancer cells.
• Evidence is preliminary, and clinical applicability remains unknown.